News for 'SARS'

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Covid deaths could touch 1 million by August: Lancet

Covid deaths could touch 1 million by August: Lancet

Rediff.com8 May 2021

If that outcome were to happen, the Modi government would be responsible for presiding over a self-inflicted national catastrophe.

USFDA denies Covaxin emergency use nod, to take 'full approval' route

USFDA denies Covaxin emergency use nod, to take 'full approval' route

Rediff.com11 Jun 2021

In a setback that could potentially delay the launch of Bharat Biotech's Covid-19 vaccine Covaxin in USA, the Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.

Vaxed pregnant women pass antibodies to babies: Study

Vaxed pregnant women pass antibodies to babies: Study

Rediff.com23 Sep 2021

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, according to a study.

Unplanned vaccination can promote mutant strains: Experts to PM

Unplanned vaccination can promote mutant strains: Experts to PM

Rediff.com10 Jun 2021

A group of public health experts, including doctors from All India Institute of Medical Sciences and members from the national taskforce on COVID-19, have said that mass, indiscriminate and incomplete vaccination can trigger emergence of mutant strains and recommended that there is no need to inoculate those who had documented coronavirus infection.

FAQ: Is it safe to take antibody cocktail for Covid-19?

FAQ: Is it safe to take antibody cocktail for Covid-19?

Rediff.com10 Jun 2021

According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.

Vaccines will work against new COVID-19 variant: Govt

Vaccines will work against new COVID-19 variant: Govt

Rediff.com29 Dec 2020

'Most vaccines do target the Spike protein, in which there are changes in the variants but vaccines stimulate our immune system to produce a wide range of protective antibodies'

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Rediff.com28 Apr 2021

The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

'No indication Omicron is more infectious or lethal'

'No indication Omicron is more infectious or lethal'

Rediff.com30 Nov 2021

'Mortality or hospitalisation has not increased in South Africa because of the new variant.' 'There is nothing to show so far that it is more infectious.' 'I am of the opinion that at the moment, there is no reason to panic.'

India saw 18% drop in new Covid cases, 13% fall in deaths from Oct 11-17

India saw 18% drop in new Covid cases, 13% fall in deaths from Oct 11-17

Rediff.com20 Oct 2021

India reported an 18 per cent decrease in the new COVID-19 cases along with a 13 per cent decline in the number of deaths during the week of October 11 to 17, the World Health Organisation has said, highlighting that all the regions globally, except the European region, reported a fall in new weekly cases of the deadly virus.

How Gulzar created Chhaiyyan Chhaiyyan

How Gulzar created Chhaiyyan Chhaiyyan

Rediff.com31 Jan 2019

'I believe after Shailendra's Mera Joota Hai Japaani in Raj Kapoor's Shree 420, Chhaiyyan Chhaiyyan is now the Indian film song that is recognised the world over -- millions know it as 'the train song'.'

'Delta plus' variant may trigger 3rd wave in Maha: State health dept

'Delta plus' variant may trigger 3rd wave in Maha: State health dept

Rediff.com17 Jun 2021

The highly virulent 'Delta plus' variant of the novel coronavirus could stoke a third wave in Maharashtra, according to a presentation made at a meeting attended by Chief Minister Uddhav Thackeray.

Covid vax tweak can help against new variants: Guleria

Covid vax tweak can help against new variants: Guleria

Rediff.com20 Dec 2021

The COVID-19 vaccines can be "tweaked" to provide protection against new variants of the virus, All India Institute of Medical Sciences (AIIMS), Delhi, Director Dr Randeep Guleria said.

No one safe until all vaccinated for Covid: Johns Hopkins scientist

No one safe until all vaccinated for Covid: Johns Hopkins scientist

Rediff.com22 Apr 2022

Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster

Delta variant 8 times less sensitive to vaccines: Study

Delta variant 8 times less sensitive to vaccines: Study

Rediff.com5 Jul 2021

The study, which was conducted on more than 100 healthcare workers at three centres in India including Sir Ganga Ram Hospital, found that the B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-Delta infections (Ct value of 16.5 versus 19) but also generates greater transmission among the fully vaccinated HCWs.

India reports 6 cases of UK coronavirus strain

India reports 6 cases of UK coronavirus strain

Rediff.com29 Dec 2020

All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.

Oxford launches COVID-19 vaccine study on children

Oxford launches COVID-19 vaccine study on children

Rediff.com13 Feb 2021

This new trial, a single-blind, randomised Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the ChAdOx1 nCoV-19 vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm.

Hema Malini's Stunning Dance Performance

Hema Malini's Stunning Dance Performance

Rediff.com5 Jan 2022

The Top Videos of the Week!

'Vaccine Must Go To Older People First'

'Vaccine Must Go To Older People First'

Rediff.com9 Nov 2021

'At the current time, we should be vaccinating all those who are potentially going to get more severe illness, before we start vaccinating very young individuals.'

Good news! Fall in new Covid cases in Kerala, Maharashtra

Good news! Fall in new Covid cases in Kerala, Maharashtra

Rediff.com18 Aug 2021

After breaching the value of 1 in the first week of August, the R number, which reflects how rapidly the coronavirus pandemic is spreading, has been steadily ebbing, according to researchers at the Institute of Mathematical Sciences, Chennai.

Health secy reviews status of passengers from UK

Health secy reviews status of passengers from UK

Rediff.com23 Dec 2020

Union Health Secretary Rajesh Bhushan reviewed the status of passengers coming from the UK to India and found positive in Maharashtra, Karnataka, Telangana, Tamil Nadu, West Bengal, Goa, Punjab, Gujarat and Kerala and their response measures in a meeting held through video conferencing.

Don't wait for economy to recover. Invest NOW!

Don't wait for economy to recover. Invest NOW!

Rediff.com10 Jul 2020

'If we wait to invest only after the economy recovers fully, it might be too late,' advises Vivek Jain, business unit head-investments, Policybazaar.com.

Saudi Arabia suspends international travel over new Covid strain

Saudi Arabia suspends international travel over new Covid strain

Rediff.com21 Dec 2020

All people who have arrived in Saudi Arabia from European countries, as well as other states where the new coronavirus strain has emerged, will have to self-isolate at home for two weeks. Those who have visited these countries in the past three months will need to get tested for Covid-19, according to SPA.

Equities outperform bonds in the ultra-long run, says study

Equities outperform bonds in the ultra-long run, says study

Rediff.com16 Mar 2021

Ultra-long term equity investments have been a lot more rewarding than debt, a study published by Credit Suisse Research Institute in collaboration with London Business School shows. "Over the last 121 years, global equities have provided an annualised real return (in dollar terms) of 5.3 per cent versus 2.1 per cent for bonds," shows the study, which has looked at returns for 23 countries since 1900. In the Indian context, equity returns are even more favourable. Since 1953, equities have generated annualised returns of 6.5 per cent and government bonds only 0.4 per cent.

Wastewater containing coronavirus may be potential threat

Wastewater containing coronavirus may be potential threat

Rediff.com25 Aug 2020

According to the scientists, sewage leaking into natural watercourses might lead to infection with the novel coronavirus SARS-CoV-2 via airborne spray.

Blanket bans can be counterproductive: WHO India head

Blanket bans can be counterproductive: WHO India head

Rediff.com18 Jan 2022

Stressing on the need to protect both lives and livelihoods, he said public health action in India and across the world must be continually guided by evidence from four key questions -- how transmissible is the variant, severity of the disease it causes, how well vaccines and prior SARS-CoV-2 infection protect and how common people perceive risk and follow control measures.

ICMR plans to scale-up testing capacity to 1 lakh/day

ICMR plans to scale-up testing capacity to 1 lakh/day

Rediff.com6 Apr 2020

The ICMR has approved over 200 labs (both public and private) for COVID-19 testing through-PCR machines.

New smartphone-based COVID test gives results in less than 30 minutes

New smartphone-based COVID test gives results in less than 30 minutes

Rediff.com7 Dec 2020

The research found that the device accurately detected a set of positive samples in under 5 minutes.

Coronavirus can last on face masks for a week: Study

Coronavirus can last on face masks for a week: Study

Rediff.com6 Apr 2020

'If you want to protect yourself just maintain good hygiene, wash your hands often and try not to touch your face, your mouth or nose without cleaning first'

Delta variant may spread as easily as chickenpox: Reports

Delta variant may spread as easily as chickenpox: Reports

Rediff.com30 Jul 2021

The Delta variant is more transmissible than the viruses that cause MERS, SARS, Ebola, the common cold, the seasonal flu and smallpox, and it is as contagious as chickenpox, according to the document, a copy of which was also obtained by The New York Times.

Maha, Kerala, K'taka log more Omicron cases; India's tally rises to 126

Maha, Kerala, K'taka log more Omicron cases; India's tally rises to 126

Rediff.com18 Dec 2021

The Centre has warned it is likely that the spread of the new variant will outpace the Delta variant where there is community transmission.

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Rediff.com27 Jul 2021

An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covid vaccine Covovax on children aged 2 to 17 years with certain conditions, official sources said.

Pfizer jab produces less antibodies against Delta variant: Study

Pfizer jab produces less antibodies against Delta variant: Study

Rediff.com4 Jun 2021

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

Second round of sero survey begins in Mumbai

Second round of sero survey begins in Mumbai

Rediff.com10 Aug 2020

The study will provide information about the spread of the infection and also throw light on herd immunity.

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

Rediff.com17 Aug 2020

Nobel laureate Peter Doherty says his 'big worry' is there could be refusals for other vaccines if doubts over its safety turn out to be true.

Omicron's mildness a 'mistake', Covid not getting milder: UK expert

Omicron's mildness a 'mistake', Covid not getting milder: UK expert

Rediff.com6 Jan 2022

The reduced severity of the Omicron variant is good news for now, but it is the result of an 'evolutionary mistake' and does not indicate that the virus which causes COVID-19 is becoming less virulent, a leading Indian-origin scientist from the University of Cambridge warned on Thursday.

Does India need booster shots to fight Omicron?

Does India need booster shots to fight Omicron?

Rediff.com12 Dec 2021

'Better to prevent than to wait for evidence. Protection delayed can also mean protection denied'

COVID-19 vaccine unlikely before Fall of 2021: Experts

COVID-19 vaccine unlikely before Fall of 2021: Experts

Rediff.com2 Oct 2020

Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology in late June 2020. The majority of those surveyed were mostly Canadian or American academics with an average of 25 years of experience working in the field.

After slowing down in early August, Covid spread rises sharply

After slowing down in early August, Covid spread rises sharply

Rediff.com3 Sep 2021

The R-value, which reflects how rapidly coronavirus pandemic is spreading, has sharply risen close to 1.2 over the last fortnight, mainly driven by cases in states like Kerala and Maharashtra, say researchers.